WeTrials
Recruiting

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

What is this study?

This study is testing a medication called azacitidine before breast cancer surgery to see how it affects immune cells inside the tumor. Researchers want to find out if this medicine can help the body's immune system fight high-risk early-stage breast cancer more effectively.

Who can participate?

You may be able to join if you are 18 or older, able to do daily activities, and have been diagnosed with certain types of early-stage breast cancer that have not yet been treated with chemotherapy, radiation, or immunotherapy.

What will happen?

Participants will receive a low dose of the study medication before their scheduled breast cancer surgery. Doctors will compare tissue samples taken before and after treatment to see how the tumor and immune cells responded.

Where and when?

This study is currently recruiting participants and takes place in Chicago, Illinois. Your care team can help you find out exact clinic details if you are interested.

Key Points
  • 1Tests a pre-surgery medication called azacitidine for high-risk breast cancer
  • 2Looking at how the treatment affects immune cells inside the tumor
  • 3Currently recruiting patients in Chicago, Illinois

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Breast Cancer InvasiveEarly-stage Breast CancerHigh Risk Breast Carcinoma

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.